Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

UKONS 2017 | The rarer toxicities of immunotherapy

Liz Gifford • 10 Nov 2017
UKONS 2017
General

Immunotherapies can induce a range of common, as well as rare, side effects. These may be difficult for healthcare professionals to spot if they have not observed them previously. In this interview, Liz Gifford of the University Hospital Southampton NHS Foundation Trust, Southampton, UK, discusses some of the rarer toxicities that can be seen in cancer patients. This video was recorded at the UK Oncology Nursing Society (UKONS) Annual Conference 2017 in Harrogate, UK.

More from Liz Gifford

1:30
The systemic anti-cancer dataset (SACT): optimizing immunotherapy toxicity management
Liz Gifford • 10 Nov 2017
0:40
Center experience: immunotherapy in Southampton
Liz Gifford • 10 Nov 2017
0:42
Acute oncology: new immunotherapy guidelines
Liz Gifford • 10 Nov 2017

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals